Methods of treating fibromyalgia with compositions comprising psilocybin
AssigneeTRYP Therapeutics Inc.
InventorsJames GILLIGAN, Peter GUZZO
Life of this patent
Estimating the term…
Abstract
Provided are methods for treating fibromyalgia or one or more symptoms thereof, that involve the administration of psychedelics, such as psilocybin or a metabolite thereof, and related uses of the psychedelics. The disclosure in some aspects also relates to methods for identifying subjects for treatment of fibromyalgia with administration of psychedelics. In some aspects, the treatment also involves psychotherapy. In some aspects, the subject receiving the treatment is assessed for various indicators, such as observer-rated and subject-reported outcomes, biological and clinical indicators, and combinations thereof.
Claims21
1-64. (canceled)
A method of treating fibromyalgia (FM), the method comprising:
- administering to a subject suffering from one or more symptoms of FM, one or more doses of psilocybin or an active metabolite thereof effective to induce a dissociative state;
- providing one or more integration sessions to the subject after emergence from the dissociative state;
- and
- assessing in the subject one or more indicators associated with the one or more symptoms of FM, dissociative state, treatment outcome, safety and/or is related to the subject, prior to and/or after administration of the one or more doses of psilocybin or an active metabolite thereof.
Dependencies are inferred from the claim text.